Achieving diversity and inclusion in medical research is essential for advancing healthcare, discovering novel drug therapies, and achieving overall health equity.
Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been designed and executed.
The global demand for state-of-the-art research facilities is limited by the current supply, leaving many regions unable to support innovation outside of established hubs like Boston, San D
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl